Contact information
+44 (0)1865 857254
Lynne Tucker
Business Manager
Lynne Tucker is the Business Manager for the Diabetes Trials Unit.
A Biochemistry graduate with a Postgraduate Diploma in Management Studies, Lynne has worked in academic research for over 20 years.
Having run UK and global trials and a translational research group, Lynne now focuses on facilitating and managing new research grants and contracts.
Recent publications
-
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.
Journal article
Holman RR. et al, (2017), Lancet Diabetes Endocrinol, 5, 877 - 886
-
Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes.
Journal article
Bethel MA. et al, (2016), Diabet Med, 33, 224 - 230
-
ASPIRIN GIVEN TWICE DAILY REDUCED THE PLATELET REACTIVITY MORE THAN ONCE DAILY IN PEOPLE WITH TYPE 2 DIABETES WITHOUT CARDIOVASCULAR DISEASE
Journal article
YiHong S. et al, (2013), HEART, 99, E249 - E250
-
Evaluation of a self-administered oral glucose tolerance test.
Journal article
Bethel MA. et al, (2013), Diabetes Care, 36, 1483 - 1488
-
Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes (AFORRD): a randomised controlled trial.
Journal article
Holman RR. et al, (2009), Diabetologia, 52, 50 - 59